2025 H1 -tulosraportti
136 päivää sitten38 min
Tarjoustasot
Oslo Børs
Määrä
Osto
2 970
Myynti
Määrä
150 776
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 4 000 | - | - | ||
| 425 | - | - | ||
| 1 | - | - | ||
| 7 688 | - | - | ||
| 8 591 | - | - |
Ylin
5,25VWAP
Alin
5,07VaihtoMäärä
4,9 962 766
VWAP
Ylin
5,25Alin
5,07VaihtoMäärä
4,9 962 766
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 H1 -tulosraportti | 29.8.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2024 H2 -tulosraportti | 26.2.2025 | |
| 2024 Q4 -tulosraportti | 26.2.2025 | |
| 2024 H1 -tulosraportti | 30.8.2024 |
Datan lähde: FactSet, Quartr
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·4 t sittenhttps://medwatch.no/nyheter/legemidler_biotek/article18908187.ece The JP. Morgan Health Care Conference in San Francisco is considered one of the year's most important arenas for capital and transactions within global life science. The conference, which opens its 44th edition on Monday, is a central reference point also for the Norwegian health industry. Pharmaceutical companies traditionally use the occasion to announce large deals with associated ambitions for the future. At the conference, the large pharmaceutical companies and the largest investors meet. Up to 10,000 investors, pharmaceutical companies and biotech companies gather to negotiate partnerships and acquisitions. Several major transactions have already been announced in advance of this year's conference: Eli Lilly has, among others, bought the biotech company Ventyx Biosciences for 1.2 billion dollars, while Amgen has announced the acquisition of Dark Blue Therapeutics with a total value of up to 840 million dollars, according to Danish MedWatch. Among those present is Innovasjon Norge, along with a selection of Norwegian health and biotech companies seeking capital from American investors. Innovasjon Norge has been a regular participant at this meeting place for many years- – We have been present at this meeting place for many years and gathered the Norwegian community at an event together with the consulate in San Francisco, states Tone Varslot Stave, head of health at Innovasjon Norge, to MedWatch, These are among the Norwegian companies at JP Morgan: Oivi Akigai Artbio Dossier Synplan Laerdalmillionlivesfund UiO Innovation Norway Circio Avant Oncoinvent Lytix Biopharma Photocure Domore Diagnostics
·10 t sitten · MuokattuMust has NOT sold, he is just no longer on the top 50 list. If one checks here; https://www.aksjeeierregisteret.no one will see that he is still listed with 700 000 pcs shares. But what has happened is that he has fallen out of the top 50 list. Is now in 51st place.
·16 t sittenNews Summary (AI) The latest shareholder updates from Oslo Børs indicate a significant change for Thor Medical. MUST INVEST AS, previously a prominent investor, has sold its stake in the company. These changes, reflecting transactions from three days earlier, suggest a shift in Thor Medical's investor base.
·10 t sittenI can't find Must with any transactions at all when I search the register at Finansavisen, but it's quite clearly stated in the list under today's updates in here. Given that it's true, I find it interesting. He is known as the investor who "never" sells, so it will be exciting to get the definitive answer on who is out and in here. I had, by the way, missed that Ulf Huse bought in for 1,22mill on 07.01.26.
·1 päivä sittenWhat is needed to get the firm grip on the cup confirmed?
·1 päivä sittenMy view based on the 6-month chart. Thor has, in my assessment, formed a relatively nice cup formation: an increase towards ~5 in Aug/Sep, rounded bottom around 3.3–3.5 in Oct/Nov, and then a controlled increase back towards previous peak levels. Resistance around 5.0–5.1 has now been tested several times and is about to be broken. What remains for a classic cup with handle confirmation is a calm consolidation/pullback (handle), preferably above 4.6–4.8, with lower volume than during the ascent. If the stock manages to stay above 5 and then makes a new breakout upwards on increased volume, it will technically be a strong confirmation of a continued trend. Such a pattern often provides room for the next upward impulse. At the same time, it's worth noting that this is not a pure trading stock – fundamental news will still be what practically drives larger movements. In my opinion.
·1 päivä sittenKI says, This is one of the better cup structures I have seen on OSE in the last year But: no handle = no full confirmation Patience here is an advantage, not a weakness :)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 H1 -tulosraportti
136 päivää sitten38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·4 t sittenhttps://medwatch.no/nyheter/legemidler_biotek/article18908187.ece The JP. Morgan Health Care Conference in San Francisco is considered one of the year's most important arenas for capital and transactions within global life science. The conference, which opens its 44th edition on Monday, is a central reference point also for the Norwegian health industry. Pharmaceutical companies traditionally use the occasion to announce large deals with associated ambitions for the future. At the conference, the large pharmaceutical companies and the largest investors meet. Up to 10,000 investors, pharmaceutical companies and biotech companies gather to negotiate partnerships and acquisitions. Several major transactions have already been announced in advance of this year's conference: Eli Lilly has, among others, bought the biotech company Ventyx Biosciences for 1.2 billion dollars, while Amgen has announced the acquisition of Dark Blue Therapeutics with a total value of up to 840 million dollars, according to Danish MedWatch. Among those present is Innovasjon Norge, along with a selection of Norwegian health and biotech companies seeking capital from American investors. Innovasjon Norge has been a regular participant at this meeting place for many years- – We have been present at this meeting place for many years and gathered the Norwegian community at an event together with the consulate in San Francisco, states Tone Varslot Stave, head of health at Innovasjon Norge, to MedWatch, These are among the Norwegian companies at JP Morgan: Oivi Akigai Artbio Dossier Synplan Laerdalmillionlivesfund UiO Innovation Norway Circio Avant Oncoinvent Lytix Biopharma Photocure Domore Diagnostics
- ·10 t sitten · MuokattuMust has NOT sold, he is just no longer on the top 50 list. If one checks here; https://www.aksjeeierregisteret.no one will see that he is still listed with 700 000 pcs shares. But what has happened is that he has fallen out of the top 50 list. Is now in 51st place.
- ·16 t sittenNews Summary (AI) The latest shareholder updates from Oslo Børs indicate a significant change for Thor Medical. MUST INVEST AS, previously a prominent investor, has sold its stake in the company. These changes, reflecting transactions from three days earlier, suggest a shift in Thor Medical's investor base.·10 t sittenI can't find Must with any transactions at all when I search the register at Finansavisen, but it's quite clearly stated in the list under today's updates in here. Given that it's true, I find it interesting. He is known as the investor who "never" sells, so it will be exciting to get the definitive answer on who is out and in here. I had, by the way, missed that Ulf Huse bought in for 1,22mill on 07.01.26.
- ·1 päivä sittenWhat is needed to get the firm grip on the cup confirmed?·1 päivä sittenMy view based on the 6-month chart. Thor has, in my assessment, formed a relatively nice cup formation: an increase towards ~5 in Aug/Sep, rounded bottom around 3.3–3.5 in Oct/Nov, and then a controlled increase back towards previous peak levels. Resistance around 5.0–5.1 has now been tested several times and is about to be broken. What remains for a classic cup with handle confirmation is a calm consolidation/pullback (handle), preferably above 4.6–4.8, with lower volume than during the ascent. If the stock manages to stay above 5 and then makes a new breakout upwards on increased volume, it will technically be a strong confirmation of a continued trend. Such a pattern often provides room for the next upward impulse. At the same time, it's worth noting that this is not a pure trading stock – fundamental news will still be what practically drives larger movements. In my opinion.
- ·1 päivä sittenKI says, This is one of the better cup structures I have seen on OSE in the last year But: no handle = no full confirmation Patience here is an advantage, not a weakness :)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
2 970
Myynti
Määrä
150 776
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 4 000 | - | - | ||
| 425 | - | - | ||
| 1 | - | - | ||
| 7 688 | - | - | ||
| 8 591 | - | - |
Ylin
5,25VWAP
Alin
5,07VaihtoMäärä
4,9 962 766
VWAP
Ylin
5,25Alin
5,07VaihtoMäärä
4,9 962 766
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 H1 -tulosraportti | 29.8.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2024 H2 -tulosraportti | 26.2.2025 | |
| 2024 Q4 -tulosraportti | 26.2.2025 | |
| 2024 H1 -tulosraportti | 30.8.2024 |
Datan lähde: FactSet, Quartr
2025 H1 -tulosraportti
136 päivää sitten38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 H1 -tulosraportti | 29.8.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2024 H2 -tulosraportti | 26.2.2025 | |
| 2024 Q4 -tulosraportti | 26.2.2025 | |
| 2024 H1 -tulosraportti | 30.8.2024 |
Datan lähde: FactSet, Quartr
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·4 t sittenhttps://medwatch.no/nyheter/legemidler_biotek/article18908187.ece The JP. Morgan Health Care Conference in San Francisco is considered one of the year's most important arenas for capital and transactions within global life science. The conference, which opens its 44th edition on Monday, is a central reference point also for the Norwegian health industry. Pharmaceutical companies traditionally use the occasion to announce large deals with associated ambitions for the future. At the conference, the large pharmaceutical companies and the largest investors meet. Up to 10,000 investors, pharmaceutical companies and biotech companies gather to negotiate partnerships and acquisitions. Several major transactions have already been announced in advance of this year's conference: Eli Lilly has, among others, bought the biotech company Ventyx Biosciences for 1.2 billion dollars, while Amgen has announced the acquisition of Dark Blue Therapeutics with a total value of up to 840 million dollars, according to Danish MedWatch. Among those present is Innovasjon Norge, along with a selection of Norwegian health and biotech companies seeking capital from American investors. Innovasjon Norge has been a regular participant at this meeting place for many years- – We have been present at this meeting place for many years and gathered the Norwegian community at an event together with the consulate in San Francisco, states Tone Varslot Stave, head of health at Innovasjon Norge, to MedWatch, These are among the Norwegian companies at JP Morgan: Oivi Akigai Artbio Dossier Synplan Laerdalmillionlivesfund UiO Innovation Norway Circio Avant Oncoinvent Lytix Biopharma Photocure Domore Diagnostics
- ·10 t sitten · MuokattuMust has NOT sold, he is just no longer on the top 50 list. If one checks here; https://www.aksjeeierregisteret.no one will see that he is still listed with 700 000 pcs shares. But what has happened is that he has fallen out of the top 50 list. Is now in 51st place.
- ·16 t sittenNews Summary (AI) The latest shareholder updates from Oslo Børs indicate a significant change for Thor Medical. MUST INVEST AS, previously a prominent investor, has sold its stake in the company. These changes, reflecting transactions from three days earlier, suggest a shift in Thor Medical's investor base.·10 t sittenI can't find Must with any transactions at all when I search the register at Finansavisen, but it's quite clearly stated in the list under today's updates in here. Given that it's true, I find it interesting. He is known as the investor who "never" sells, so it will be exciting to get the definitive answer on who is out and in here. I had, by the way, missed that Ulf Huse bought in for 1,22mill on 07.01.26.
- ·1 päivä sittenWhat is needed to get the firm grip on the cup confirmed?·1 päivä sittenMy view based on the 6-month chart. Thor has, in my assessment, formed a relatively nice cup formation: an increase towards ~5 in Aug/Sep, rounded bottom around 3.3–3.5 in Oct/Nov, and then a controlled increase back towards previous peak levels. Resistance around 5.0–5.1 has now been tested several times and is about to be broken. What remains for a classic cup with handle confirmation is a calm consolidation/pullback (handle), preferably above 4.6–4.8, with lower volume than during the ascent. If the stock manages to stay above 5 and then makes a new breakout upwards on increased volume, it will technically be a strong confirmation of a continued trend. Such a pattern often provides room for the next upward impulse. At the same time, it's worth noting that this is not a pure trading stock – fundamental news will still be what practically drives larger movements. In my opinion.
- ·1 päivä sittenKI says, This is one of the better cup structures I have seen on OSE in the last year But: no handle = no full confirmation Patience here is an advantage, not a weakness :)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
2 970
Myynti
Määrä
150 776
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 4 000 | - | - | ||
| 425 | - | - | ||
| 1 | - | - | ||
| 7 688 | - | - | ||
| 8 591 | - | - |
Ylin
5,25VWAP
Alin
5,07VaihtoMäärä
4,9 962 766
VWAP
Ylin
5,25Alin
5,07VaihtoMäärä
4,9 962 766
Välittäjätilasto
Dataa ei löytynyt